How affordable is TB care? Findings from a nationwide TB patient cost survey in Ghana.

Tropical Medicine & International Health : TM & IH
Debora PedrazzoliJ Borghi

Abstract

Tuberculosis (TB) is known as a disease of the poor. Despite TB diagnosis and care usually being offered for free, TB patients can still face substantial costs, especially in the context of multi-drug resistance (MDR). The End TB Strategy calls for zero TB-affected families incurring 'catastrophic' costs due to TB by 2025. This paper examines, by MDR status, the level and composition of costs incurred by TB-affected households during care seeking and treatment; assesses the affordability of TB care using catastrophic and impoverishment measures; and describes coping strategies used by TB-affected households to pay for TB care. A nationally representative survey of TB patients at public health facilities across Ghana. We enrolled 691 patients (66 MDR). The median expenditure for non-MDR TB was US$429.6 during treatment, vs. US$659.0 for MDR patients (P-value = 0.001). Catastrophic costs affected 64.1% of patients. MDR patients were pushed significantly further over the threshold for catastrophic payments than DS patients. Payments for TB care led to a significant increase in the proportion of households in the study sample that live below the poverty line at the time of survey compared to pre-TB diagnosis. Over half of patients ...Continue Reading

References

May 1, 1998·American Journal of Respiratory and Critical Care Medicine·K B Weiss, W W Addington
Nov 6, 2003·Health Economics·Adam Wagstaff, Eddy van Doorslaer
Apr 6, 2005·Tropical Medicine & International Health : TM & IH·Alexis CambanisLuis E Cuevas
Dec 20, 2005·Journal of Epidemiology and Community Health·Bruna GalobardesGeorge Davey Smith
Jan 18, 2006·Journal of Epidemiology and Community Health·Bruna GalobardesGeorge Davey Smith
Aug 30, 2007·The Journal of Infectious Diseases·Paul NunnKevin M De Cock
Jul 20, 2007·Bulletin of the World Health Organization·Dermot MaherMarcos Espinal
Nov 4, 2008·The European Respiratory Journal·J-P Janssens, H L Rieder
Nov 26, 2008·Bulletin of the World Health Organization·Diane McIntyreJane Goudge
Sep 15, 2011·International Journal of Health Care Finance and Economics·Mohammad Hajizadeh, Hong Son Nghiem
Nov 28, 2012·PloS One·Olivia Oxlade, Megan Murray
Feb 15, 2013·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·V MauchE Klinkenberg
Apr 20, 2013·Bulletin of the World Health Organization·Samia LaokriBruno Dujardin
Feb 15, 2014·The European Respiratory Journal·Tadayuki TanimuraKnut Lönnroth
Mar 31, 2015·Lancet·Mukund UplekarUNKNOWN for WHO's Global TB Programme
Feb 10, 2017·The European Respiratory Journal·Debora PedrazzoliKatharina Kranzer
Aug 2, 2017·Vaccine· World Health Organization

❮ Previous
Next ❯

Citations

Jul 4, 2020·The American Journal of Tropical Medicine and Hygiene·Susan M McAllisterBachti Alisjahbana
Jun 20, 2019·Infectious Diseases of Poverty·Cai-Hong XuLi Wang
Feb 27, 2020·International Journal of Environmental Research and Public Health·Qian LongShenglan Tang
Mar 13, 2021·BMC Public Health·Lesley-Ann Lynnath CannonDaniel Ter Goon
Jun 17, 2021·Acta Neurologica Scandinavica·Xue-Ping MaRong Yang
Jul 22, 2021·Epidemiologia E Serviços De Saúde : Revista Do Sistema Unico De Saúde Do Brasil·Márcia Regina de Oliveira PedrosoEthel Leonor Noia Maciel
Jul 1, 2021·Tropical Medicine & International Health : TM & IH·Collins TimireCharles Sandy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.